The good news is they appear to be behind us, or a
Post# of 148170
(Total Views: 511)
Posted On: 05/26/2022 7:15:42 PM
Re: Evil Rabbit #123823
The good news is they appear to be behind us, or at least not ahead of us, but gaining ground quickly. I wonder how it does on reversing the scarring. This may turn out to be a positive in our favor because it will pressure other BP's to get going, and we're looking for a partnership.
"Now, the treatment is being studied in an ongoing Phase II clinical trial evaluating the impact of the treatment on the resolution of NASH or improvement in liver fibrosis. The study is anticipated to be completed in 2024 and will inform a future Phase III clinical trial, including an arm that will investigate ervogastat as a monotherapy."
"Now, the treatment is being studied in an ongoing Phase II clinical trial evaluating the impact of the treatment on the resolution of NASH or improvement in liver fibrosis. The study is anticipated to be completed in 2024 and will inform a future Phase III clinical trial, including an arm that will investigate ervogastat as a monotherapy."
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
My comments are just my opinions and should NOT be taken as investment advice.
Scroll down for more posts ▼